Leukemia, Myeloid, Chronic-Phase
"Leukemia, Myeloid, Chronic-Phase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The initial phase of chronic myeloid leukemia consisting of an relatively indolent period lasting from 4 to 7 years. Patients range from asymptomatic to those exhibiting ANEMIA; SPLENOMEGALY; and increased cell turnover. There are 5% or fewer blast cells in the blood and bone marrow in this phase.
MeSH Number(s)
C04.557.337.539.250.400
C15.378.190.636.370.400
Concept/Terms
Leukemia, Myeloid, Chronic-Phase- Leukemia, Myeloid, Chronic-Phase
- Granulocytic Leukemia, Chronic, Stable-Phase
- Leukemia, Granulocytic, Chronic Phase
- Leukemia, Granulocytic, Chronic-Phase
- Leukemia, Myelogenous, Chronic Phase
- Leukemia, Myelogenous, Chronic-Phase
- Leukemia, Myeloid, Chronic Phase
- Leukemia, Myeloid, Stable Phase
- Leukemia, Myeloid, Stable-Phase
- Myelogenous Leukemia, Chronic, Chronic Phase
- Myelogenous Leukemia, Chronic, Chronic-Phase
- Myeloid Leukemia, Chronic, Chronic Phase
- Myeloid Leukemia, Chronic, Chronic-Phase
- Myeloid Leukemia, Chronic, Stable-Phase
- Granulocytic Leukemia, Chronic, Stable Phase
Below are MeSH descriptors whose meaning is more general than "Leukemia, Myeloid, Chronic-Phase".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Leukemia [C04.557.337]
- Leukemia, Myeloid [C04.557.337.539]
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive [C04.557.337.539.250]
- Leukemia, Myeloid, Chronic-Phase [C04.557.337.539.250.400]
- Hemic and Lymphatic Diseases [C15]
- Hematologic Diseases [C15.378]
- Bone Marrow Diseases [C15.378.190]
- Myeloproliferative Disorders [C15.378.190.636]
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive [C15.378.190.636.370]
- Leukemia, Myeloid, Chronic-Phase [C15.378.190.636.370.400]
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Myeloid, Chronic-Phase".
This graph shows the total number of publications written about "Leukemia, Myeloid, Chronic-Phase" by people in Harvard Catalyst Profiles by year, and whether "Leukemia, Myeloid, Chronic-Phase" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
2000 | 2 | 0 | 2 |
2003 | 0 | 1 | 1 |
2004 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2008 | 2 | 0 | 2 |
2011 | 0 | 1 | 1 |
2012 | 2 | 1 | 3 |
2013 | 3 | 0 | 3 |
2014 | 2 | 0 | 2 |
2015 | 1 | 0 | 1 |
2016 | 3 | 0 | 3 |
2019 | 1 | 0 | 1 |
2020 | 2 | 0 | 2 |
2021 | 2 | 0 | 2 |
2022 | 1 | 0 | 1 |
2023 | 2 | 0 | 2 |
2024 | 2 | 0 | 2 |
Below are the most recent publications written about "Leukemia, Myeloid, Chronic-Phase" by people in Profiles.
-
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 02; 22(1):43-69.
-
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials. Leukemia. 2024 Mar; 38(3):475-481.
-
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921. J Clin Oncol. 2024 Mar 01; 42(7):821-831.
-
Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis. Haematologica. 2023 06 01; 108(6):1567-1578.
-
Ponatinib after failure of second-generation tyrosine kinase inhibitor in resistant chronic-phase chronic myeloid leukemia. Am J Hematol. 2022 11; 97(11):1419-1426.
-
Low-dose dasatinib: when less can be more. Lancet Haematol. 2021 12; 8(12):e867-e868.
-
Future Directions in Chronic Phase CML Treatment. Curr Hematol Malig Rep. 2021 12; 16(6):500-508.
-
BCR-ABL1 transcript doubling time as a predictor for treatment-free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase. Br J Haematol. 2022 01; 196(1):136-145.
-
Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 10 01; 18(10):1385-1415.
-
Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients. Leuk Lymphoma. 2020 12; 61(12):2811-2820.